Pembrolizumab,Lenvatinib,Regorafenib,Trifluridine Tipiracil
Merck,Eisai,Bayer,Taiho pharma,Pfizer
['crcsm', 'gi ', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
yesterday's sessions are now available on demand current immuno-oncology approaches &amp; the future for new combinations in gi cancers talk by dr. morelli, md, phd #asco23 #crcsm
new approaches: anti-lag-3 tregs?
combi+io, safe, but ? about effectiveness 
Pt Adv, NCI Rectal Anal TF
Mom
Vety Dr 
Lifelong learner
Wants to bring pt voice to research clinical trials & more!
Check out @CRCTrialsChat
1st love: Virology